Appropriate Use of Oral Antibiotics in Children
儿童适当使用口服抗生素
基本信息
- 批准号:7342425
- 负责人:
- 金额:$ 14.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-01-01 至 2009-12-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAdolescent MedicineAge-YearsAntibiotic TherapyAntibioticsAreaBostonBreast FeedingChildChild DevelopmentChildhoodClinical Research Curriculum AwardCommitDiagnosisDoctor of MedicineEnrollmentFacultyFoundationsGoalsInstitutional National Research Service AwardIron deficiency anemiaLow incomeMaternal and Child HealthMentorsMidcareer Investigator Award in Patient-Oriented ResearchMinorityMothersOralOtitis MediaPainPediatricsPeer ReviewPractice based researchPremature InfantProceduresProgram DevelopmentPublic HealthPublishingRandomizedRandomized Controlled TrialsResearchResearch Project GrantsResidenciesServicesSleepTherapy Clinical TrialsTrainingUniversitiesWood materialcareermedical schoolspatient oriented researchprofessorprograms
项目摘要
DESCRIPTION (provided by applicant): Howard Bauchner, M.D., Professor of Pediatrics and Public Health at Boston University School of Medicine (BUSM), is applying for a Midcareer Investigator Award in Patient-Oriented Research (K24). Dr. Bauchner completed his post-residency training as a Robert Wood Johnson Foundation General Pediatric Academic Fellow at Yale-New Haven in 1986. He joined the faculty at BUSM that year, was promoted to Associate Professor in 1990 and Professor in 1997. Dr. Bauchner's career has been committed to conducting patient-oriented research, and mentoring fellows and faculty in general pediatrics. His own research has focused on randomized controlled trials, methodologic reviews, and therapeutic trials in the areas of sleep, painful procedures, inappropriate oral antibiotic use, and iron deficiency anemia. He has published 60 peer-reviewed articles, and over the past five years conducted six studies in the area of inappropriate oral antibiotic use. Currently, with support from GlaxoSmithKline, he is beginning a practice-based research project in which 12 practices will be randomized to information about the appropriate antibiotics therapy or appropriate diagnosis of acute otitis media (AOM). In this study, it is estimated that 3600 children less than three years of age will be enrolled. The goal is to determine if children with AOM treated with appropriate antibiotics do better than children treated with inappropriate antibiotics. With support from the Maternal and Child Health Bureau, he is also conducting a randomized controlled trial that is focused on increasing the percentage of low-income and minority mothers who breastfeed their premature infants. In addition to his own research efforts, Dr. Bauchner is Project Director of an Institutional National Research Service Award and Faculty Development Program. With support from these two programs, four fellows have been in training each year for the past eight years. These fellows all require intensive mentoring and are conducting patient-oriented research. With support from this program, Dr. Bauchner will commit 50% effort to conducting patient-oriented research and mentoring. He will expand his mentoring efforts to include fellows and faculty in the Divisions of Pediatric Emergency Room Services, Child Development and Adolescent Medicine, and become a senior advisor to the CREST Program (K30) at BUSM.
描述(由申请人提供):霍华德·鲍克纳,医学博士,波士顿大学医学院(BUSM)儿科学和公共卫生教授,正在申请以患者为中心的研究(K24)职业中期研究员奖。鲍克纳博士于1986年作为罗伯特·伍德·约翰逊基金会普通儿科学者在耶鲁-纽黑文完成了住院医师后的培训。同年,他进入北京理工大学任教,1990年被提升为副教授,1997年被提升为教授。鲍克纳博士的职业生涯一直致力于开展以患者为导向的研究,并指导普通儿科的研究员和教职员工。他自己的研究集中在睡眠、痛苦的程序、不适当的口服抗生素使用和缺铁性贫血领域的随机对照试验、方法学审查和治疗试验。他发表了60篇同行评议的文章,在过去的五年里,他在口服抗生素不当使用领域进行了六项研究。目前,在葛兰素史克的支持下,他正在开始一项以实践为基础的研究项目,其中12项实践将被随机分配到关于适当的抗生素治疗或适当诊断急性中耳炎(AOM)的信息中。在这项研究中,预计将有3600名三岁以下儿童入学。目的是确定接受适当抗生素治疗的AOM儿童是否比接受不适当抗生素治疗的儿童表现更好。在妇幼保健局的支持下,他还进行了一项随机对照试验,重点是增加低收入和少数族裔母亲母乳喂养早产儿的比例。除了他自己的研究工作,鲍切纳博士还是机构国家研究服务奖和教师发展计划的项目主任。在这两个项目的支持下,在过去的八年里,每年都有四名研究员接受培训。这些研究员都需要密集的指导,并正在进行以患者为导向的研究。在这个项目的支持下,鲍克纳博士将投入50%的精力进行以患者为导向的研究和指导。他将扩大他的指导努力,包括儿科急诊室服务、儿童发展和青少年医学部的研究员和教师,并成为BUSM CREST计划(K30)的高级顾问。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The grand challenges of the Gates Foundation: what impact on global child health?
盖茨基金会面临的重大挑战:对全球儿童健康有何影响?
- DOI:10.1177/014107680609900412
- 发表时间:2006
- 期刊:
- 影响因子:17.3
- 作者:Litzow,JenniferM;Bauchner,Howard
- 通讯作者:Bauchner,Howard
Retrospective evaluation of a computerized physician order entry adaptation to prevent prescribing errors in a pediatric emergency department.
- DOI:10.1542/peds.2007-3064
- 发表时间:2008-10
- 期刊:
- 影响因子:8
- 作者:Sard BE;Walsh KE;Doros G;Hannon M;Moschetti W;Bauchner H
- 通讯作者:Bauchner H
A.S.P.E.N. clinical guidelines: nutrition support of hospitalized pediatric patients with obesity.
阿斯彭
- DOI:10.1177/0148607109354088
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Jesuit,Cheryl;Dillon,Cristin;Compher,Charlene;AmericanSocietyforParenteralandEnteralNutrition(A.S.P.E.N.)BoardofDirectors;Lenders,CarineM
- 通讯作者:Lenders,CarineM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOWARD BAUCHNER其他文献
HOWARD BAUCHNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOWARD BAUCHNER', 18)}}的其他基金
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 14.24万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 14.24万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 14.24万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 14.24万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 14.24万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 14.24万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 14.24万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 14.24万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 14.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 14.24万 - 项目类别:
Operating Grants